Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows – News-Medical.net
News-Medical.net |
Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows
News-Medical.net A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared … |
